Cargando…

Autophagy-Related Three-Gene Prognostic Signature for Predicting Survival in Esophageal Squamous Cell Carcinoma

Esophageal squamous cell carcinoma (ESCC) is one of the most aggressive malignant tumors in China, and its prognosis remains poor. Autophagy is an evolutionarily conserved catabolic process involved in the occurrence and development of ESCC. In this study, we described the expression profile of auto...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Heyang, Weng, Yongjia, Ding, Ning, Cheng, Chen, Wang, Longlong, Zhou, Yong, Zhang, Ling, Cui, Yongping, Zhang, Weimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8321089/
https://www.ncbi.nlm.nih.gov/pubmed/34336650
http://dx.doi.org/10.3389/fonc.2021.650891
_version_ 1783730768815587328
author Cui, Heyang
Weng, Yongjia
Ding, Ning
Cheng, Chen
Wang, Longlong
Zhou, Yong
Zhang, Ling
Cui, Yongping
Zhang, Weimin
author_facet Cui, Heyang
Weng, Yongjia
Ding, Ning
Cheng, Chen
Wang, Longlong
Zhou, Yong
Zhang, Ling
Cui, Yongping
Zhang, Weimin
author_sort Cui, Heyang
collection PubMed
description Esophageal squamous cell carcinoma (ESCC) is one of the most aggressive malignant tumors in China, and its prognosis remains poor. Autophagy is an evolutionarily conserved catabolic process involved in the occurrence and development of ESCC. In this study, we described the expression profile of autophagy-related genes (ARGs) in ESCC and developed a prognostic prediction model for ESCC patients based on the expression pattern of ARGs. We used four ESCC cohorts, GSE53624 (119 samples) set as the discovery cohort, The Cancer Genome Atlas (TCGA) ESCC set (95 samples) as the validation cohort, 155 ESCC cohort, and Oncomine cohort were used to screen and verify differentially expressed ARGs. We identified 34 differentially expressed genes out of 222 ARGs. In the discovery cohort, we divided ESCC patients into three groups that showed significant differences in prognosis. Then, we analyzed the prognosis of 34 differentially expressed ARGs. Three genes [poly (ADP-ribose) polymerase 1 (PARP1), integrin alpha-6 (ITGA6), and Fas-associated death domain (FADD)] were ultimately obtained through random forest feature selection and were constructed as an ARG-related prognostic model. This model was further validated in TCGA ESCC set. Cox regression analysis confirmed that the three-gene signature was an independent prognostic factor for ESCC patients. This signature effectively stratified patients in both discovery and validation cohorts by overall survival (P = 5.162E-8 and P = 0.052, respectively). We also constructed a clinical nomogram with a concordance index of 0.713 to predict the survival possibility of ESCC patients by integrating clinical characteristics and the ARG signature. The calibration curves substantiated fine concordance between nomogram prediction and actual observation. In conclusion, we constructed a new ARG-related prognostic model, which shows the potential to improve the ability of individualized prognosis prediction in ESCC.
format Online
Article
Text
id pubmed-8321089
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-83210892021-07-30 Autophagy-Related Three-Gene Prognostic Signature for Predicting Survival in Esophageal Squamous Cell Carcinoma Cui, Heyang Weng, Yongjia Ding, Ning Cheng, Chen Wang, Longlong Zhou, Yong Zhang, Ling Cui, Yongping Zhang, Weimin Front Oncol Oncology Esophageal squamous cell carcinoma (ESCC) is one of the most aggressive malignant tumors in China, and its prognosis remains poor. Autophagy is an evolutionarily conserved catabolic process involved in the occurrence and development of ESCC. In this study, we described the expression profile of autophagy-related genes (ARGs) in ESCC and developed a prognostic prediction model for ESCC patients based on the expression pattern of ARGs. We used four ESCC cohorts, GSE53624 (119 samples) set as the discovery cohort, The Cancer Genome Atlas (TCGA) ESCC set (95 samples) as the validation cohort, 155 ESCC cohort, and Oncomine cohort were used to screen and verify differentially expressed ARGs. We identified 34 differentially expressed genes out of 222 ARGs. In the discovery cohort, we divided ESCC patients into three groups that showed significant differences in prognosis. Then, we analyzed the prognosis of 34 differentially expressed ARGs. Three genes [poly (ADP-ribose) polymerase 1 (PARP1), integrin alpha-6 (ITGA6), and Fas-associated death domain (FADD)] were ultimately obtained through random forest feature selection and were constructed as an ARG-related prognostic model. This model was further validated in TCGA ESCC set. Cox regression analysis confirmed that the three-gene signature was an independent prognostic factor for ESCC patients. This signature effectively stratified patients in both discovery and validation cohorts by overall survival (P = 5.162E-8 and P = 0.052, respectively). We also constructed a clinical nomogram with a concordance index of 0.713 to predict the survival possibility of ESCC patients by integrating clinical characteristics and the ARG signature. The calibration curves substantiated fine concordance between nomogram prediction and actual observation. In conclusion, we constructed a new ARG-related prognostic model, which shows the potential to improve the ability of individualized prognosis prediction in ESCC. Frontiers Media S.A. 2021-07-15 /pmc/articles/PMC8321089/ /pubmed/34336650 http://dx.doi.org/10.3389/fonc.2021.650891 Text en Copyright © 2021 Cui, Weng, Ding, Cheng, Wang, Zhou, Zhang, Cui and Zhang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Cui, Heyang
Weng, Yongjia
Ding, Ning
Cheng, Chen
Wang, Longlong
Zhou, Yong
Zhang, Ling
Cui, Yongping
Zhang, Weimin
Autophagy-Related Three-Gene Prognostic Signature for Predicting Survival in Esophageal Squamous Cell Carcinoma
title Autophagy-Related Three-Gene Prognostic Signature for Predicting Survival in Esophageal Squamous Cell Carcinoma
title_full Autophagy-Related Three-Gene Prognostic Signature for Predicting Survival in Esophageal Squamous Cell Carcinoma
title_fullStr Autophagy-Related Three-Gene Prognostic Signature for Predicting Survival in Esophageal Squamous Cell Carcinoma
title_full_unstemmed Autophagy-Related Three-Gene Prognostic Signature for Predicting Survival in Esophageal Squamous Cell Carcinoma
title_short Autophagy-Related Three-Gene Prognostic Signature for Predicting Survival in Esophageal Squamous Cell Carcinoma
title_sort autophagy-related three-gene prognostic signature for predicting survival in esophageal squamous cell carcinoma
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8321089/
https://www.ncbi.nlm.nih.gov/pubmed/34336650
http://dx.doi.org/10.3389/fonc.2021.650891
work_keys_str_mv AT cuiheyang autophagyrelatedthreegeneprognosticsignatureforpredictingsurvivalinesophagealsquamouscellcarcinoma
AT wengyongjia autophagyrelatedthreegeneprognosticsignatureforpredictingsurvivalinesophagealsquamouscellcarcinoma
AT dingning autophagyrelatedthreegeneprognosticsignatureforpredictingsurvivalinesophagealsquamouscellcarcinoma
AT chengchen autophagyrelatedthreegeneprognosticsignatureforpredictingsurvivalinesophagealsquamouscellcarcinoma
AT wanglonglong autophagyrelatedthreegeneprognosticsignatureforpredictingsurvivalinesophagealsquamouscellcarcinoma
AT zhouyong autophagyrelatedthreegeneprognosticsignatureforpredictingsurvivalinesophagealsquamouscellcarcinoma
AT zhangling autophagyrelatedthreegeneprognosticsignatureforpredictingsurvivalinesophagealsquamouscellcarcinoma
AT cuiyongping autophagyrelatedthreegeneprognosticsignatureforpredictingsurvivalinesophagealsquamouscellcarcinoma
AT zhangweimin autophagyrelatedthreegeneprognosticsignatureforpredictingsurvivalinesophagealsquamouscellcarcinoma